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In tro duc ti on
There is a growing interest in the non-skeletal effects 
of vitamin D in recent years (1). There are some reports 
suggesting that vitamin D deficiency has a negative effect 
on insulin sensitivity and that it increases type 2 diabetes
prevalence in adults (2,3,4,5). Some studies establishing a
relationship between vitamin D and insulin sensitivity in 
children have also been published (6,7).  Recently, high rates
of vitamin D deficiency have been reported in children with
type 1 diabetes (T1D) and it is emphasized that this situation
may have a negative effect on bone health (8,9,10,11,12,13).
A positive effect of vitamin D administered in high doses (4000
IU/day) on metabolic control has also been reported (14).
However, prevalence of vitamin D deficiency in children with
T1D and its effects on metabolic control, insulin requirement
and lipid levels have not yet been fully clarified. 
In this study, we aimed to investigate the frequency and
effects of vitamin D deficiency in children with T1D. A high rate
of vitamin D deficiency is encountered among adolescents in
our region (15).
Materials and Methods
The study group consisted of one hundred twenty 
patients with T1D who were being followed in our pediatric
endocrinology outpatient clinic. The mean age of patients was
12.7±3.8 years (range: 2.9-20.1 years). Fifty four percent of the
patients (n=65) were boys and 46% (n=55) were girls. 
ABS TRACT
Ob jec ti ve: To investigate the frequency and effects of vitamin D 
deficiency in children with type 1 diabetes (T1D) in a region which is
known to have a high rate of vitamin D deficiency among adolescents. 
Met hods:  In this prospective cross-sectional study, 120 children and
adolescents with T1D (55 girls and 65 boys) aged 3-20 years were 
evaluated. Serum 25-hydroxyvitamin D [25(OH)D], parathormone (PTH),
and alkaline phosphatase (ALP) levels were measured. Hemoglobin A1c
levels and daily insulin requirement were also evaluated.  Classification
of vitamin D status was made according to the American Academy of
Pediatrics (AAP)/LWEPS’s recommendations. The patients were divided
into 2 groups according to their vitamin D status and also according to
the season of the year in which 25(OH)D sampling was done.  
Re sults: Serum 25(OH)D levels revealed vitamin D deficiency or 
insufficiency in 38% of the patients. Higher PTH levels were found in the
patient group whose mean 25(OH)D level was <20 ng/mL as compared
to the group whose mean 25(OH)D level was >20 ng/mL (p<0.05). 
Only 11% of patients had secondary hyperparathyroidism. The 25(OH)D
levels of patients whose serum samples were taken in summer 
and spring months were significantly different (p<0.05). There were no
significant correlations between 25(OH)D level and daily insulin dose.   
Conc lu si on:  Although we could not show a significant association
between vitamin D deficiency and metabolic parameters, the frequency
of vitamin D deficiency in T1D children is substantial. Vitamin D status
should be assessed also in patients who do not have signs of rickets.  
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Serum 25-hydroxyvitamin D [25(OH)D], parathormone (PTH),
and alkaline phosphatase (ALP) levels were measured.
Hemoglobin A1c (HbA1c) levels (mean of the measurements
of the preceding year) and daily insulin requirement of 
the patients were evaluated. The season in which 25(OH)D
samples were taken was also recorded. 
The participants were divided into two groups according to
their pubertal stage. Group 1 consisted of prepubertal children
(n=29) and group 2 - of children who had reached puberty (n=91). 
Because vitamin D status is associated with sunlight
exposure, a variable which changes with the season of the
year, the participants were categorized according to 25(OH)D
sampling season: winter (December 22-March 21), spring
(March 22-June 21), summer (June 22-September 21), and
fall (September 22-December 21).
Vitamin D status was classified according to the American
Academy of Pediatrics (AAP)/LWEPS’s recommendations on
cut-off levels for states of vitamin D. A 25(OH)D level of <5
ng/mL (<12.5 nmol/L) was considered as severe deficiency, 
a level between 5 and 15 ng/mL (12.5-37.5 nmol/L) as 
deficiency, a level of 15-20 ng/mL (37.5-50 nmol/L) as 
insufficiency, and a level of 20-100 ng/mL (50-250 nmol/L) as
normal (sufficient) (16).  Our patients were also divided into 
2 groups according to their vitamin D status. Those 
with 25(OH)D levels <20 ng/mL were grouped as vitamin D
insufficient and deficient,  and those with 25(OH)D levels >20
ng/mL as normal with regard to vitamin D status.
Serum 25(OH)D level was measured by ELISA reader and
the microELISA method.  Serum level of ALP was measured
using a Beckman CX-9 autoanalyzer. Serum PTH was 
measured by an original assay using Roche Diagnostics 
E-170 Modular Analytics immunoanalyzer equipment. The
manufacturer’s normal range for PTH was 15-65 pg/mL and
intra- and interassay CVs were 2.8 and 3.4%, respectively.
Secondary hyperparathyroidism was defined as a PTH 
level greater than 65 pg/mL. HbA1c levels were measured by
high-performance liquid chromatography (HPLC).
The statistical analyses were performed with SPSS 13.0
software for Windows (SPSS Inc., Chicago, IL, USA). Mean
values were compared using the Student’s t-test 
and Analysis of Variance (ANOVA). Pearson’s correlation
analysis was used to reveal the relationships between
25(OH)D levels and daily insulin requirement of patients. The
results were expressed as mean±SD. A p-value of less than
0.05 was considered statistically significant.
Results 
The demographic and biochemical features of the
patients are shown in Table 1. Serum 25(OH)D levels in
37.5% (n=45) of the patients revealed vitamin D deficiency or
insufficiency. 0.8% (n=1) of patients had severe vitamin D
deficiency. 21.7% (n=26) had vitamin D deficiency, and 15%
(n=18) had vitamin D insufficiency. The 25(OH)D status level
was normal (sufficient) in 60% (n=72) of the patients. A small
fraction of the patients, 2.5% (n=3), had vitamin D excess.
No significant differences were found between the
25(OH)D levels of girls and boys. The mean 25(OH)D level of
the girls was 25.5±21.1 ng/mL (range: 4.6-101) and that of the
boys was 25.8±10.7 ng/mL (range: 10.9-56.4), (p>0.05). Only
five girls (9%) wore concealing clothes for religious reasons.
The serum 25(OH)D levels of these five girls were 9, 13.7,
11.6, 101, and 16.1 ng/mL; the mean 25(OH)D level was
30.3±39.5 ng/mL (median= 13.7 ng/mL).
180
Mutlu A et al.
Vitamin D Deficiency and Type 1 Diabetes
Tab le  1. Demographic and biochemical features of patients 
Age  12.7±3.8 years (2.9-20.1)
Gender  Girls: 46% (n=55) 
Boys: 54% (n=65)
Duration of T1D  3.2±2.3 years (0.7-12.8)
Daily insulin requirement (U/kg/d) 0.87±0.24 (0.16-1.5)
HbA1c (%) 8.2±1.4 (5.5-12.9)
25(OH)D  25.6±16.2 ng/mL (4.6-101)
ALP  237.6±116.9 u/L (39-746)
PTH  38.9±18.3 pg/mL (12.8-97.7)
T1D: type 1 diabetes, HbA1c: hemoglobin A1c, 25(OH)D: 25-hydroxyvitamin D, 
ALP: alkaline phosphatase, PTH: parathormone
Tab le  2. The comparison of prepubertal and pubertal participants
Prepubertal Pubertal p  value
n=29 (24%) n=91 (76%)
Age (years)
Mean±SD 7.6±2.6 14.3±2.5
p<0.01
Range 2.9-11.8 8.8-20.1
Sex 
Male 21 (72.4%) 44 (48.4%) p<0.05
Female 8 (27.6%) 47 (51.6%)
Duration of T1D (years)
Mean 2.5±1.3 3.9±2.5
p<0.01
Range 0-6.3 0-12.9
HbA1c (%)
Mean 8±1.2 8.3±1.5
NS
Range 6.1-12 5.5-12.9
25(OH)D (ng/mL)
Mean   26.4±11.9 25.4±17.4
NS
Range 10.9-56.4 5.5-12.9
Frequency of vitamin 
9 (31%) 36 (39.6%) NS
D deficiency/insufficiency
Data are presented as n (%) unless otherwise indicated
HbA1c: hemoglobin A1c, 25(OH)D: 25-hydroxyvitamin D, T1D: type 1 diabetes, 
NS: Not significantTwenty four percent (n=29) of the study group was 
prepubertal and 76% (n=91) was pubertal. The mean
25(OH)D levels in the prepubertal and pubertal groups were
similar (26.4±11.9 and 25.4±17.4 ng/mL, respectively,
p>0.05). The characteristics of the prepubertal and pubertal
participants are given in Table 2. There was no difference
between prepubertal and pubertal patients in terms of 
metabolic control and vitamin D status.
In the 45 patients (37.5%) whose mean 25(OH)D level was
lower than 20 ng/mL, the mean PTH level was 44.6±24 pg/mL
and the mean ALP level was 237±137.6 U/L. In the 75
patients (62.5%) whose mean 25(OH)D level was higher than
20 ng/mL, the mean PTH level was 35.5±12.8 pg/mL and the
mean ALP level was 237±103.4 U/L. PTH levels in the group
whose mean 25(OH)D level was lower than 20 ng/mL were
significantly higher than in the other subgroup whose mean
25(OH)D level was greater than 20 ng/mL (p<0.05). Only 13
patients (10.8%) had secondary hyperparathyroidism. There
was no significant difference in terms of daily insulin
requirement and HbA1c% in the two groups (Table 3). Also,
there was no significant correlation between 25(OH)D level
and daily insulin dose (r=-0.07, p>0.05). 
The rates of 25(OH)D samples taken at different time of
the year were as follows: 42% in the summer, 23% in the
winter, 21% in the spring, and 14% in the fall. The mean
25(OH)D levels of patients according to the seasons were
respectively: 30.4±10.4 ng/mL, 24.8±26.7 ng/mL, 17.5±7.3
ng/mL and 25±11.2 ng/mL. One-way ANOVA showed
significant differences between the means (p<0.05). The
significant result was caused by the difference in 25(OH)D
levels of patients whose serum samples were taken in the
summer and those of patients whose samples were taken in
the spring. Mean serum PTH, ALP and 25(OH)D levels of
patients according to season are shown in Table 4. 
Discussion
In recent years, studies suggesting that vitamin D
deficiency correlates with the severity and frequency of T1D
and that vitamin D supplementation reduces the risk of
developing T1D have been reported  (17,18). On the other
hand, although the number of studies on frequency of vitamin
D deficiency in children and adolescents with T1D is limited,
this frequency was found to be highly variable and may be as
low as 15% or as high as 90.6% (10,11,13,19,20) (Table 5).
Studies indicating that T1D patients have lower vitamin D
levels than control groups have also been reported
(8,9,10,12). 
In this study, we found the prevalence of vitamin D
deficiency in children with T1D as 21.7% and our results
were similar to those reported by Svoren et al (11) and Tunc
et al (19). The reasons for the different frequencies given
from different countries for vitamin D deficiency could be
related to the variability of vitamin D deficiency definition
(Table 5). Geographical environment and latitude may have
influenced this variability (e.g., the latitudes of countries/
cities listed in Table 5 were: Boston: 42°19’ North,
Switzerland: 47°00’ North, Qatar: 25°15’ North, Ankara
39°55’ and Kocaeli: 40°45’ North). 
Despite the high frequency of vitamin D deficiency (65%)
in healthy adolescents in our region, we found the frequency
of vitamin D deficiency in T1D children lower than that
reported for healthy subjects (15). However, the limitation of
this present study is the absence of an age- and gender-
matched control group.
Although the mean PTH level of the vitamin D insufficient
group was below the cut-off value for hyperparathyroidism, it
was significantly higher than that of the vitamin D sufficient
group. We observed secondary hyperparathyroidism only in
10.8% of all patients whose vitamin D level was lower than 
20 ng/mL. Janner et al (20) had found the prevalence of
secondary hyperparathyroidism low in vitamin D deficient
T1D patients as well. These findings indicate that all vitamin
D deficient T1D patients do not have secondary
hyperparathyroidism. Similarly, in a study from our region,
secondary hyperparathyroidism frequency was very low (3%)
among vitamin D deficient/insufficient adolescent girls who
were known to be otherwise healthy (15). 
There are recent publications discussing the effects of
vitamin D supplementation and even active vitamin D
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Tab le  3. The comparison of vitamin D sufficient and insufficient/deficient patients
Vitamin D status Insufficient / deficient Sufficient p value
25(OH)D level <20 ng/mL  25(OH)D level >20 ng/mL 
n=45 (36.5%) n=72 (60%)
ALP (U/L) 237±137.6 237±103.4 NS
PTH (pg/mL) 44.6±24 35.5±12.8 0.02*
HbA1c (%) 8.1±1.4 8.3±1.5 NS
Daily insulin requirement(U/kg/d) 0.86±0.22 0.88±0.28 NS
*significant: p<0.05; NS: non-significant; 
HbA1c: hemoglobin A1c, 25(OH)D: 25-hydroxyvitamin D,  ALP: alkaline phosphatase, PTH: parathormonetreatment on the metabolic control of diabetic patients
(14,21). On the other hand, the number of studies on the
relation of 25(OH)D levels with daily insulin requirement and
metabolic control in children is limited. Johnson et al (22)
found an inversely proportional correlation between fasting
blood sugar level and 25(OH)D in pediatric outpatients.
Svoren et al (11) and Tunc et al (19) showed that low serum
25(OH)D levels were associated with poor metabolic control
in T1D patients. In our study, we did not find a significant
correlation between serum 25(OH)D levels and HbA1c or
duration of diabetes. Similarly, Janner et al (20) had reported
that there was no relationship between HbA1c levels and
vitamin D status in T1D children and adolescents. The daily
insulin requirements of our subjects also did not change with
their vitamin D status. 
In conclusion, although we could not show a significant
association between vitamin D deficiency and metabolic
parameters, the frequency of vitamin D deficiency in T1D
children can be substantial. Vitamin D status of these children
should be assessed in terms of bone health. Even in the
absence of signs of rickets, vitamin D supplementation must
be suggested to vitamin D deficient T1D children.
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